We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INFQ:NYSEInfleqtion, Inc. analysis

Data as of Oct 2, 2026 - not real-time

Latest price
$13.67
Risk: high
9/10High risk

Summary

Infleqtion, Inc. is priced at $13.67, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have gained 8.9%. With RSI at 52.9 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $12.29 and resistance at $15.06.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 59.7% above today's level. Revenue is growing at 156.5% on a -167.8% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 74.1%, a beta of 4.16 and a maximum drawdown of 55.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.

Top market events

  • Infleqtion, Inc. INFQ shares were volatile on Thursday as traders digested second-quarter results that paired a big...
  • Infleqtion’s strong revenue growth and raised 2026 outlook failed to prevent an after-hours drop as an earnings per...
  • Infleqtion NYSE:INFQ has entered a new subcontract with Eaton to apply quantum computing to power grid reliability and...

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading above the 200-day average of 12.61
  • MACD momentum is negative
  • 30-day price change of +8.9%

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading above the 200-day average of 12.61
  • Analyst targets imply +59.7% versus the current price
  • 30-day volatility of 74.1%

Long term

> 3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Negative profit margin of -167.8%
  • Analyst targets imply +59.7% versus the current price
  • Revenue growth of +156.5%

Key metrics

Financial health

Revenue Growth156.50%
Profit Margin-167.79%
P/E Ratio-60.8
Debt/Equity2.53
P/B Ratio5.3
Op. Cash Flow$-20392000
Industry P/E35.6

Technical analysis

TrendNeutral
RSI52.9
Support$12.29
Resistance$15.06
MA 20$13.51
MA 50$12.57
MA 200$12.61
MACDBearish
VolumeDecreasing
Fear & Greed Index93.64

Valuation

Target Price$21.83
Upside/Downside59.72%
GradeFair
TypeGrowth

Risk assessment

Beta4.16
Volatility74.11%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.